Association between obesity and a polymorphism in the β1-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women

被引：0

作者：

IJ Dionne

MJ Garant

AA Nolan

TI Pollin

DG Lewis

AR Shuldiner

ET Poehlman

机构：

[1] Clinical Pharmacology and Metabolic Research Unit,Department of Medicine

[2] University of Vermont,Division of Endocrinology, Department of Medicine

[3] Diabetes and Nutrition,Département de Nutrition

[4] and Baltimore Veterans Administration Geriatric Research and Education Clinical Center,undefined

[5] University of Maryland,undefined

[6] Research Center on Aging,undefined

[7] Geriatric Institute of University of Sherbrooke,undefined

[8] Faculté de Médecine,undefined

[9] Université de Montréal,undefined

来源：

International Journal of Obesity | 2002年 / 26卷

关键词：

body weight; body mass index; fat mass; energy balance; genetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Introduction: Genetic variants affecting adrenoceptors have been suggested to influence body fatness. A putative gain-of-function polymorphism in the β1-adrenoceptor was recently discovered (Gly389Arg ADRB1). We examined the association between Gly389Arg ADRB1 and obesity status in a large cohort of well-characterized individuals.

引用

页码：633 / 639

页数：6

共 50 条

[21] β1-adrenoceptor Arg389Gly polymorphism and heart disease: marching toward clinical practice integration
McCrink, Katie A.
Lymperopoulos, Anastasios
PHARMACOGENOMICS, 2015, 16 (10) : 1035 - 1038
[22] Distributive characteristics of Ser49Gly and Gly389Arg genetic polymor-phisms of β1-adrenoceptor in Chinese Han and Dai populations
Zhao-qian LIU Jie LIU Zhi-hua XIANG Min-yu HU Wei MO Lian-sheng WANG Dong-sheng OU-YANG Nan HE Dan WANG Hong-hao ZHOU Pharmacogenetics Research Institute
ActaPharmacologicaSinica, 2006, (02) : 254 - 258
[23] Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis Potosí and León,México
Celia Aradillas-García
Miguel Cruz
Elva Perez-Luque
Maria E.Garay-Sevilla
Juan M.Malacara
Aduna R
Jesús Peralta
Ana Burguete-García
Jorge A.Alegría-Torres
The Journal of Biomedical Research, 2017, 31 (01) : 40 - 46
[24] Gly389Arg polymorphism of β1-adenergic receptor is associated with the cardiovascular response to metoprolol
Liu, J
Liu, ZQ
Tan, ZR
Chen, XP
Wang, LS
Zhou, G
Zhou, HH
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) : 372 - 379
[25] The Gly389Arg β1-adrenergic receptor polymorphism:: A predictor of response to β-blocker treatment?
Brodde, OE
Stein, CM
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) : 299 - 302
[26] The Gly389Arg polymorphism determines the activation kinetics of the human β1-adrenergic receptor
Ahles, A.
Rochais, F.
Rodewald, F.
Buenemann, M.
Engelhardt, S.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 4 - 4
[27] β1-adrenoceptor Arg389Gly polymorphism confers differential β-arrestin-binding tropism in cardiac myocytes
McCrink, Katie A.
Brill, Ava
Jafferjee, Malika
Valero, Thairy Reyes
Marrero, Christine
Rodriguez, Martha M.
Hale, Genevieve M.
Lymperopoulos, Anastasios
PHARMACOGENOMICS, 2016, 17 (15) : 1611 - 1620
[28] Molecular modeling study about consequences of human β1 adrenoceptor Ser49Gly and Gly389Arg polymorphisms
Correa-Basurto, Jose
Cipres, Fabiola
Trujillo-Ferrara, Jose G.
Antonio Soriano-Ursua, Marvin
FASEB JOURNAL, 2010, 24
[29] The Arg389Gly β1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine
Leineweber, K
Bruck, H
Temme, T
Heusch, G
Philipp, T
Brodde, OE
PHARMACOGENETICS AND GENOMICS, 2006, 16 (01): : 9 - 13
[30] Inotropic catecholamine support after coronary artery bypass surgery in relation to Arg389Gly β1-adrenoceptor polymorphism
Leineweber, K
Bruck, H
Brodde, OE
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (05) : 612 - 612

← 1 2 3 4 5 →